Citation Impact
Citing Papers
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Chemical Composition and Antibacterial Activities of Illicium verum Against Antibiotic-Resistant Pathogens
2010
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
In Vitro Activities of Tigecycline, Ertapenem, Isepamicin,and Other Antimicrobial Agents Against Clinically IsolatedOrganisms in Taiwan
2005
Emergence of Nosocomial Candidemia at a Teaching Hospital in Taiwan from 1981 to 2000: Increased Susceptibility of Candida Species to Fluconazole
2002
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Leishmaniasis
2018 Standout
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina
2005
Separation methods for methotrexate, its structural analogues and metabolites
2001
Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System
2005
Open Babel: An open chemical toolbox
2011 Standout
Lead- and drug-like compounds: the rule-of-five revolution
2004 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs
2003
Illicium verum: A review on its botany, traditional use, chemistry and pharmacology
2011 Standout
The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site
1989
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents
2005
Pasteurization is effective against multidrug-resistant bacteria
2006
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
2007
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Antimicrobial resistance in developing countries. Part I: recent trends and current status
2005
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009
2011
Biomedical applications of biodegradable polymers
2011 Standout
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland
2007
Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
1997 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Pulmonary Absorption Rate and Bioavailability of Drugs in Vivo in Rats: Structure–Absorption Relationships and Physicochemical Profiling of Inhaled Drugs
2003
Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
2017
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Nanoporous Carbohydrate Metal–Organic Frameworks
2011 StandoutNobel
Improved Nasal Bioavailability of FITC-Dextran (Mw4300) from Mucoadhesive Microspheres in Rabbits
1999
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study
2005
Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs
2009
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
2006 Standout
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
2006 Standout
Essential oils from aromatic herbs as antimicrobial agents
2011 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles
2010
Mobile Health Technology Evaluation
2013 Standout
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
2004
Analysis of anticancer drugs: A review
2011 Standout
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii
2007
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature
2006
Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001
2006
Self-Emulsifying Drug Delivery Systems (SEDDS): Formulation Development, Characterization, and Applications
2009
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome
2006
The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000
2004
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres
2008
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
2004
Chitosan microspheres as a potential carrier for drugs
2004 Standout
Gender differences in drug responses
2006
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
In Vitro and In Vivo Characterizations of Pegylated Liposomal Doxorubicin
2011
Multidrug-ResistantAcinetobacter baumannii
2005
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
2002
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study
2015
Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model
1995
New epidemiology of Staphylococcus aureus infection in Asia
2014
admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties
2012 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
An Overview on Assessing Agreement with Continuous Measurements
2007
Review: A History of Cyclodextrins
2014 Standout
Bioequivalence trials, intersection-union tests and equivalence confidence sets
1996
Difluorobenzocyclooctyne: Synthesis, Reactivity, and Stabilization by β-Cyclodextrin
2010 StandoutNobel
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension
2005
Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of Hospitalization
2007
Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
2012
Unbiased Recursive Partitioning: A Conditional Inference Framework
2006 Standout
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
2018
Pharmacokinetics of 7-carboxymethyloxy-3‘,4’,5-trimethoxy flavone (DA-6034), a derivative of flavonoid, in mouse and rat models of chemically-induced inflammatory bowel disease
2005
Point-of-Care Diagnostics for Global Health
2008 Standout
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
2011 Standout
Binary Classification of Aqueous Solubility Using Support Vector Machines with Reduction and Recombination Feature Selection
2011
Dissemination of a Clone of Unusual Phenotype of Pandrug-Resistant Acinetobacter baumannii at a University Hospital in Taiwan
2004
Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
2006
Edible nanoemulsions: fabrication, properties, and functional performance
2010 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Drug delivery strategies for poorly water-soluble drugs
2007
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Mei‐Ling Chen being referenced
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
2002
Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics
2000
Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report
2011
Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing?
1996
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
2007
Instantaneous input Hypothesis in Pharmacokinetic Studies
1981
Measures of Exposure versus Measures of Rate and Extent of Absorption
2001
Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report
2004
Assuring quality and performance of sustained and controlled release parenterals: Workshop report
2002
Antimicrobial Drug Resistance in Pathogens Causing Nosocomial Infections at a University Hospital in Taiwan, 1981-1999
2002
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration
1983
Pharmacokinetics of drugs in blood I. Unusual distribution of gentamicin
1981
Individual bioequivalence—a regulatory update
1997
Determination of Tissue to Blood Partition Coefficients in Physiologically-Based Pharmacokinetic Studies
1982
Adsorption of Methotrexate Onto Glassware and Syringes
1982
The Use of Drug Metabolism for Prediction of Intestinal Permeability
2009